Strata Critical operates one of the largest air transport and clinical services networks for organ transplant and cardiac surgery providers.
NASDAQ: $SRTA
Strata acquires Louisville Perfusion Services, expanding our cardiac perfusion platform across Kentucky and the Midwest, and making us an even stronger partner to hospitals and transplant centers.
Thank you to @aktien_max and Simon @topsecretstocks for having our leadership team on the show!
Will Heyburn, Melissa Tomkiel and Mat Schneider covered our One-Call Platform, DCD/NRP growth, M&A strategy and the long-term vision for Strata Critical — building the national infrastructure backbone for organ logistics, recovery, placement and transplant.
The opportunity is significant. We hope you'll tune in.
https://t.co/2oRH6RzBSp
$SRTA: I’m hosting Strata Critical Co-CEOs Will Heyburn and Melissa Tomkiel to discuss Q1 Results and 2026 Outlook.
Monday May 11th @ 11AM ET
https://t.co/VS0FANHZrg
Congratulations to @TGHCares on reaching 15,000 transplants! As Tampa General's dedicated logistics partner, we're proud to have played a small role in supporting this incredible milestone. Here's to many more!
https://t.co/mOQhKF4vJO
Strata 1Q 2026 organic year-over-year revenue and gross profit growth of 32% and 30% respectively. Clinical sequential revenue and gross profit growth of 13% and 29% respectively. Reiterating 2026 guidance. We will host a conference call at 8am ET.
https://t.co/vD4bNmGp7P
Strata is releasing Q1 2026 earnings tomorrow before market open and will hold a conference call to discuss the results at 8 am ET (link below). If you have questions, please send them to [email protected].
https://t.co/PVD9w02cld
Strata's acquisition of Ohio Valley Perfusion Associates reflects our disciplined approach to M&A: accretive bolt-ons in fragmented, recurring-revenue end markets that complement our existing clinical operations. Cardiac perfusion remains a core growth pillar alongside our organ recovery and transplant vertical.
Today's Press Release: https://t.co/LB9S18E1oX
$SRTA
Groundbreaking research from the University of Pittsburgh shows liver transplant recipients trained to accept donor organs without lifelong immunosuppression. A small study, but a massive signal for the future of transplant medicine. Every advance in transplant outcomes starts with a successful recovery and delivery. That's what we do.
https://t.co/lh39PyElon
Strata is releasing Q1 2026 earnings on May 6th before market open and will hold a call to discuss the results at 8 am ET (link below). If you have questions, we would love to hear from you! Please send them to [email protected], and management will pick several to answer during the call.
https://t.co/IjmOZNnKGb
Check out the link below for a replay of Strata Critical Co-CEO Will Heyburn's discussion with analyst Matt Shea at the 25th Annual Needham Healthcare Conference.
https://t.co/x3ZWoCvW7P
Strata Critical Medical today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 1:30 pm ET. A webcast of the event will be available through the link below.
https://t.co/x3ZWoCvW7P
Approximately 5,000 Americans die every year while waiting for an organ transplant match. Dr. Montgomery, director of the NYU Langone Transplant Institute—himself a heart transplant recipient—is working to change that with gene-edited pig kidneys. This is what "Reimagining the Future of Organ Transplants" looks like. We're proud to support NYU Langone with logistics, organ recovery services, and organ placement.
https://t.co/GcYbumUl49
Strata Critical congratulates New England Donor Services on an extraordinary 2025, enabling 1,692 life-saving transplants through innovation, dedication, and operational excellence. We are proud to partner with NEDS, supporting donation opportunities that utilize Normothermic Regional Perfusion (NRP).
https://t.co/1WCTQJ9vgH
LiveOnNY, the Greater New York area OPO, launched a campaign to increase organ donation registration. Strata is a proud partner of New York's largest transplant centers. https://t.co/01DgpljgM0.
New research from NYU Langone surgeons highlights the increasing number of DCD donors (donation after circulatory death) and the key enablers including normothermic regional perfusion and machine perfusion. https://t.co/uq1BTwH5sQ
Strata 4Q 2025 organic revenue and gross profit growth of 35% and 39% respectively. Full year 2025 revenue and Adj EBITDA both beat the high end of our guidance range. Raising 2026 revenue and Adj EBITDA guidance. We will host a conference call at 8am ET.
https://t.co/ukVP4dd82J
Strata will report 4Q 2025 and full year 2025 results this coming Tuesday March 3rd at 8am ET. If you have a question, we would love to hear from you! Please send your questions to [email protected] and management will select several to address on Tuesday's call.